Cargando…
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
The new category of MiT family translocation renal cell carcinoma has been included into the World Health Organization (WHO) classification in 2016. The MiT family translocation renal cell carcinoma comprises Xp11 translocation renal cell carcinoma harboring TFE3 gene fusions and t(6;11) renal cell...
Autores principales: | Caliò, Anna, Segala, Diego, Munari, Enrico, Brunelli, Matteo, Martignoni, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721505/ https://www.ncbi.nlm.nih.gov/pubmed/31382581 http://dx.doi.org/10.3390/cancers11081110 |
Ejemplares similares
-
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors
por: Caliò, Anna, et al.
Publicado: (2021) -
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022) -
Report of two primary renal tumors with myxoid features. Differential diagnosis between benign and malignant entities
por: Fioravanzo, Adele, et al.
Publicado: (2021) -
Proteogenomic characterization of MiT family translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2022) -
Racial Disparities in MiT Family Translocation Renal Cell Carcinoma
por: Lu, Xiaofan, et al.
Publicado: (2023)